Results 91 to 100 of about 19,280 (221)

Usefulness of bioelectrical impedance analysis for monitoring patients with refractory ascites [PDF]

, 2019
Background: bioelectrical impedance analysis is a technique for the determination of the hydropic component. The hydropic component, determined by blood volume, could be a reflection of the hemodynamic situation.
Ampuero Herrojo, Javier, Borreguero, Samuel, Ontanilla-Clavijo, Guillermo, Romero Gómez, Manuel, Rosell, Javier   +4 more
core  

Clinical course and prognostic factors of hepatorenal syndrome: A retrospective single-center cohort study [PDF]

, 2013
AIM: To investigate clinical and biochemical features of hepatorenal syndrome (HRS), to assess short and long-term survival evaluating potential predictors of early mortality. METHODS: Sixty-two patients with liver cirrhosis and renal failure, defined as
Almasio, P., Bonaccorso, A., Cappello, M., Craxi, A., Licata, A., Macaluso, F., Maida, M.   +6 more
core   +1 more source

Liver Cirrhosis and In‐Hospital Outcomes in Patients With Sickle Cell Crises

eJHaem, Volume 7, Issue 2, April 2026.
ABSTRACT Introduction Sickle cell disease (SCD) is a hematologic disorder characterized by chronic hemolysis, vaso‐occlusion, and end‐organ dysfunction. Patients with SCD may experience acute episodes known as sickle cell crises, which are sudden, severe complications typically involving pain or organ‐specific manifestations resulting from vaso ...
Shakirat Gold‐Olufadi, Kayode Ogunniyi, Adeleke Oluwaseun Dorcas, Bukola Florence Tabiti, Dosbai Saparov, Chiamaka Nwachukwu, Henry Becerra, Sravani Bhavanam, Shrestha Neharika, John Ogedegbe, Ifeanyi Nnamdi Uche, Jen Chin Wang, Chinemerem Martlin Emeasoba, Dania Jaamour, Toluwalase Awoyemi   +14 more
wiley   +1 more source

Feasibility of Early Oral Nutritional Supplementation After Liver Transplantation: A Randomized Pilot Study

Clinical Transplantation, Volume 40, Issue 4, April 2026.
ABSTRACT Catabolic and inflammatory changes after liver transplantation (LT) increase energy and protein requirements. This study assessed the feasibility of a 12‐week high‐energy/high‐protein oral nutrition supplementation (ONS) initiated after resumption of solid oral intake post‐LT.
Amal Trigui, Crystèle Hogue, Mélanie Tremblay, Geneviève Huard, An Tang, Justine Racette, Christopher F. Rose, Chantal Bémeur   +7 more
wiley   +1 more source

HEPATORENAL SYNDROME

Zdravniški Vestnik, 2001
Background. Hepatorenal syndrome (HRS) is acommon complication of advanced hepatic disease characterizedby marked abnormalities in arterial circulation and byrenal failure. An extreme arteriolar vasodilatation located inthe splanchnic circulation results
Matjaž Hafner
doaj  

Early Prediction of Hepatic Decompensation in Cirrhosis Using Optimised XGBoost Models at the Initial Outpatient Hepatology Visit

Liver International, Volume 46, Issue 4, April 2026.
ABSTRACT Background and Aims Hepatic decompensation represents a critical transition in cirrhosis, leading to increased morbidity, mortality and healthcare utilisation. Identifying patients at risk of decompensation remains a clinical challenge. We aimed to develop and validate XGBoost models to predict hepatic decompensation at multiple time points ...
Micah Grubert Van Iderstine, Sem Perez, Gregory S. Jackson, Tyler Szun, Caelan Stephanson, Megan Weisshaar, Gerald Y. Minuk, Nabiha Faisal   +7 more
wiley   +1 more source

An Update on Hepatorenal Syndrome

Journal of Renal and Hepatic Disorders, 2017
Hepatorenal syndrome (HRS) is one of the many potential causes of acute kidney injury (AKI) in patients with decompensated liver disease. HRS is associated with poor prognosis and represents the end-stage of a sequence of reductions in renal perfusion ...
Samuel Chan, Kenneth Au, Ross Francis, David W Mudge, David W Johnson, Tony Rahman   +5 more
doaj   +1 more source

Effect of Hormone Replacement Therapy on Liver and Cardiometabolic Outcomes in Peri‐Menopausal MASLD

Liver International, Volume 46, Issue 4, April 2026.
ABSTRACT Background Metabolic dysfunction‐associated steatotic liver disease (MASLD) is the most common chronic liver disease globally. Menopause is associated with increased hepatic fat deposition and thus metabolic dysfunction, contributing to heightened risk of progressive liver and cardiovascular disease.
Alex E. Henney, Jo Wilson, David R. Riley, Uazman Alam, Daniel J. Cuthbertson   +4 more
wiley   +1 more source

Preventing First and Further Decompensation in Advanced Chronic Liver Disease

Liver International, Volume 46, Issue 4, April 2026.
ABSTRACT Advanced chronic liver disease (ACLD) remains a major cause of global morbidity and mortality. Preventing hepatic decompensation—both the first event and subsequent recurrences—has become a central therapeutic goal to prolong survival. The transition from the compensated phase (cACLD) to the decompensated phase (dACLD) is driven by clinically ...
Leonardo Corrêa Süffert, Bernardo de Faria Moraes, Guilherme Grossi Lopes Cançado   +2 more
wiley   +1 more source

Personalised Long‐Term Albumin Treatment Based on Three‐Month Ascites Response in Patients With Decompensated Cirrhosis

Liver International, Volume 46, Issue 4, April 2026.
ABSTRACT Background and Aims Long‐term albumin (LTA) is effective for treating ascites in decompensated cirrhosis. This study aims to analyse the clinical courses of patients receiving LTA and provide a 3 month stratification to personalise management integrating LTA with other options.
Enrico Pompili, Giulia Iannone, Salvatore Piano, Pierluigi Toniutto, Antonio Lombardo, Stefania Gioia, Marta Tonon, Roberta Gagliardi, Daniele Carrello, Greta Tedesco, Vito Di Marco, Giacomo Zaccherini, Lorenzo Lani, Maurizio Baldassarre, Silvia Nardelli, Davide Bitetto, Vincenza Calvaruso, Paolo Angeli, Paolo Caraceni   +18 more
wiley   +1 more source